ROBO Global Healthcare Technology and Innovation ETF
HTEC
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Global
- Address
- 7250 Dallas Parkway, Suite 400 Plano TX United States of America 75024
- IPO Date
- Jun 25, 2019
- CIK
- 0001452937
- Website
- roboglobaletfs.com
- Similar Companies
- Business
- ROBO Global Healthcare Technology and Innovation ETF (HTEC) is an exchange-traded fund that provides investors with targeted exposure to companies driving innovation in healthcare technology, tracking the ROBO Global Healthcare Technology and Innovation Index. Launched on June 24, 2019, and listed on NYSE Arca, the ETF holds approximately 63-65 equity securities focused on the convergence of robotics, artificial intelligence, machine intelligence, and life sciences; its core subsectors include medical instruments, diagnostics, precision medicine, genomics, process automation and lab automation, robotics, regenerative medicine, telehealth, and data analytics. The multi-cap fund offers diversified global access to large-, mid-, and small-cap companies primarily in North America (80%), Europe (18%), and Asia (3%), with top holdings such as Alnylam Pharmaceuticals, Guardant Health, CRISPR Therapeutics, Illumina, and Boston Scientific, representing around 20% of assets under management of approximately $45-50 million and a net expense ratio of 0.68%. Exchange Traded Concepts LLC serves as the investment adviser, with portfolio management led by Andrew Serowik and a team including Gabriel Tan, Todd Alberico, and Brian Cooper. The ETF maintains a quarterly rebalance frequency and emphasizes companies with significant revenue from disruptive healthcare technologies, offering minimal overlap with broad market indices. Geographically diversified across developed and emerging markets, HTEC targets the global value chain of healthcare innovation for institutional and retail investors seeking growth in diagnostics, genomics, precision and regenerative medicine, instruments, telehealth, and related fields. ROBO Global, the index sponsor with expertise in robotics, AI, and healthcare technologies, collaborates with Exchange Traded Concepts to deliver this thematic investment vehicle from operations based in the United States. In recent developments, the fund has seen periodic prospectus updates and post-effective amendments to its registration statement, reflecting ongoing regulatory compliance and portfolio adjustments as of late 2024. Performance highlights include quarterly gains and sector-specific momentum, such as strong Q4 2024 contributions from holdings like Masimo amid healthcare revenue growth and operational efficiencies, though the fund has contractually waived certain fees through August 31, 2025, to maintain cost competitiveness. No major acquisitions, partnerships, or strategic shifts specific to HTEC were reported in 2024-2025, with focus remaining on index reconstitution and exposure to high-growth healthcare innovators.